首页 | 本学科首页   官方微博 | 高级检索  
检索        


Detection and characterization of focal hepatic tumors: A comparison of T2‐weighted MR images before and after the administration of gadoxectic acid
Authors:Young Kon Kim MD  Hyo Sung Kwak MD  Chong Soo Kim MD  Young Min Han MD
Institution:Department of Diagnostic Radiology, Chonbuk National University Medical School and Hospital, Jeonbuk, South Korea
Abstract:

Purpose

To evaluate if T2‐weighted images (T2WI) after administration of gadoxetic acid have diagnostic capability comparable to precontrast T2WI in the detection and characterization of focal liver lesions.

Materials and Methods

Eighty patients with 128 liver lesions (71 hepatocellular carcinomas, 35 metastases, and 22 hemangiomas) underwent gadoxetic acid‐enhanced T1WI and precontrast and postcontrast turbo spin echo‐short tau inversion recovery (TSE‐STIR) and respiratory triggered (RT)‐TSE. The sensitivity for malignancy with combining T2WIs and enhanced T1WIs was evaluated and percentage of signal intensity loss (PSIL) and lesion‐liver contrast to noise ratio (CNR) were calculated for T2WIs. Lesion characterization with T2WIs as solid and nonsolid was evaluated using kappa statistics.

Results

The PSIL was higher with TSE‐STIR than with RT‐TSE (P = 0.0001). The malignancy‐liver CNRs on postcontrast T2WIs were higher than on precontrast T2WIs (P = 0.0001). Sensitivity for malignancy by combining postcontrast T2WIs and T1WIs (93.0% hepatocellular carcinoma, HCC]; 97.1% metastases]) was comparable to sensitivity of combining precontrast T2WIs and postcontrast T1WIs (91.6% HCC]; 88.6% metastases]). Kappa values for T2WIs indicated excellent agreement (k = 0.935).

Conclusion

Gadoxetic acid‐enhanced T2WIs showed a comparable diagnostic capability to precontrast T2WIs for the detection and characterization of hepatic tumors. J. Magn. Reson. Imaging 2009;30:437–443. © 2009 Wiley‐Liss, Inc.
Keywords:liver  neoplasm  magnetic resonance imaging  contrast agents  gadoxetic acid
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号